Product How it works Pricing Blog FAQ About Contact
Fennec Pharmaceuticals

Fennec Pharmaceuticals (NASDAQ: FENC) revenue

Fennec Pharmaceuticals reported revenue of $44.6m for fiscal 2025, 6.1% less than in fiscal 2024 ($47.5m).

Fennec Pharmaceuticals's best year of the last 8 was fiscal 2024. The biggest drop was in fiscal 2025, −6.1%.

Revenue, in millions of US dollars0.020160.020170.020180.020191.8202221.3202347.5202444.62025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$44.6m−6.1%−$6.3m−14.1%
2024$47.5m+123.7%$2.6m5.4%
2023$21.3m+1,101.4%−$12.8m−60.1%
2022$1.8m—−$22.6m−1,276.9%
2019$0.0m—−$13.0m—
2018$0.0m—−$10.4m—
2017$0.0m—−$7.0m—
2016$0.0m—−$2.9m—

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Fennec Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Fennec Pharmaceuticals ranks 332nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Fennec Pharmaceuticals, −6.1%.

RankCompanyRevenueRevenue growth
330thSepterna$46.0m4,174.5%
331stTriSalus Life Sciences$45.2m53.4%
332ndFennec Pharmaceuticals$44.6m−6.1%
333rdAquestive Therapeutics$44.5m−22.6%
334thWave Life Sciences$42.7m−60.5%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Fennec Pharmaceuticals

How much revenue did Fennec Pharmaceuticals make in fiscal 2025?
Fennec Pharmaceuticals reported revenue of $44.6m for fiscal 2025, compared with $47.5m in fiscal 2024.
What was the best year for revenue at Fennec Pharmaceuticals?
Of its last 8 fiscal years, fiscal 2024, with $47.5m.
Where does Fennec Pharmaceuticals rank in its sector by revenue?
It ranks 332nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Fennec Pharmaceuticals come from?
From the annual report (Form 10-K) that Fennec Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Fennec Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2019 · 2018 · 2017 · 2016. More on Fennec Pharmaceuticals: the Fennec Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.